V

Varian

Tech-enabled radiation oncology hardware and software

Head of Business Excellence

Full-Time
$165.9k - $228.1k+ Commission
Expert
Bachelor's, Master's
United States
Hybrid
Business & StrategyBusiness Operations
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in business, engineering, operations management, economics, or a related field is required; an advanced degree is preferred.
  • At least 10 years of experience in management or internal consulting, operational excellence, business transformation, or service operations is required.
  • Proven experience leading and developing high-potential talent, including coaching, performance management, and preparing team members for broader roles is required.
  • A track record of building systems that detect operational issues early, diagnosing root causes, and driving corrective action with line leaders is required.
  • Strong analytical and trend-analysis skills are required.
  • Ability to diagnose complex cross-functional performance issues and convert them into decision-ready business cases is required.
  • Experience redesigning end-to-end service processes by combining Lean, artificial intelligence, and automation is required.
  • Understanding of the business value and cost of artificial intelligence and automation is required.
  • The successful candidate must be able to work with controlled technology in accordance with United States export control law.
Responsibilities
  • Build and run analytics to track operational, service-delivery, workforce, and financial performance, using leading indicators to spot emerging risks early.
  • Identify service commitments at risk and gaps in ownership across the service process.
  • Define performance standards and early-warning indicators for critical operational areas.
  • Review core service workflows for automation and artificial intelligence opportunities.
  • Combine operational data with customer insights to distinguish isolated issues from systemic trends.
  • Frame each engagement with a clear problem statement, baseline, scope, and required decision.
  • Use structured, hypothesis-driven problem solving to distinguish symptoms from validated root causes.
  • Determine whether issues arise from execution, process design, technology, or data.
  • Deliver focused, time-bound engagements with clear outcomes.
  • Design future-state workflows that combine Lean methods, artificial intelligence, and automation.
  • Work with operational leaders and Human Resources to define changes needed to roles, skills, and capacity.
  • Partner with Quality and Regulatory teams to ensure designs meet safety, cybersecurity, and regulatory requirements.
  • Quantify the customer, operational, financial, and risk impact of acting and not acting.
  • Define baselines, target outcomes, effort, dependencies, risks, and benefit ownership.
  • Set and maintain business-case standards across the organization.
  • Give senior leadership clear, evidence-based recommendations.
  • Bring recommendations to the appropriate business owners for implementation.
  • Develop corrective actions with regional and functional leaders, including clear owners, timelines, and expected results.
  • Support implementation with analysis, facilitation, and hands-on problem solving until performance recovers.
  • Act as a trusted advisor during execution and escalate barriers when needed.
  • Confirm that results are delivered and owned by the business.
  • Work with Finance and business owners to verify realized benefits against plan.
  • Share outcomes and successes with leadership and recognize contributing teams.
  • Lead a small, high-performing team of high-potential talent with diverse skills.
  • Set clear goals and quality standards and hold the team accountable.
  • Coach the team in analytics, root-cause analysis, process redesign, and value engineering.
  • Grow talent through stretch assignments and exposure to senior leaders.
  • Give regular feedback and run performance and talent reviews.
  • Prepare team members for future leadership roles.
  • Build a culture of curiosity, ownership, and inclusion focused on outcomes.
Desired Qualifications
  • An advanced degree is preferred.

About the company

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

1948

Get referred to Varian

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ARPA-H awarded Varian up to $60 million in April 2026 for FLASH-RT.
  • FDA cleared TrueBeam for osteoarthritis in March 2026, opening a non-cancer market.
  • Telix collaboration and 2026 AI approvals expand Varian's clinical and software pipeline.

What critics are saying

  • RaySearch enabled online adaptive TrueBeam workflows in Belgium in May 2026, eroding software differentiation.
  • Elekta still attacks Varian's lead in adaptive radiotherapy and premium MR-guided care.
  • If FLASH and non-oncology bets fail by 2028, Varian becomes a commoditized linear-accelerator vendor.

What makes Varian unique

  • Siemens Healthineers gives Varian imaging, radiotherapy, and capital-sales integration globally.
  • Varian's 2026 CE-marked Eclipse AI contouring deepens workflow lock-in across planning.
  • TrueBeam, Halcyon, and Ethos create an installed-base moat hospitals rarely replace.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours
  • Remote Work Options
  • Paid Vacation
  • Paid Holidays
  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Wellness Program
  • 401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

3%

2 year growth

3%
Varex Imaging Corporation
Sep 14th, 2026
About Us | Varex Imaging Corporation

We strive to help customers become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster

MEDQOR
Apr 30th, 2026
Siemens Healthineers secures $83M to develop photon Flash radiotherapy for cancer treatment

Siemens Healthineers has received up to $60 million from the US Advanced Research Projects Agency for Health to develop photon Flash radiotherapy, with the company contributing an additional $23 million, totalling $83 million over five years. Flash photon therapy delivers radiotherapy more than 100 times faster than current technologies, aiming to reduce side effects and improve healthy tissue sparing. Unlike proton and electron beam platforms, which face scalability challenges, photon beams are the standard of care for over 50% of cancer patients. The project will build on existing C-arm linear accelerators to enable broader clinical access. Siemens Healthineers aims to transition ultra-high dose rate radiotherapy from experimental treatment into global standard of care within the five-year timeframe.

Business Wire
Mar 19th, 2026
Varian TrueBeam gets FDA clearance for low-dose radiotherapy to treat osteoarthritis

Siemens Healthineers has received FDA 510(k) clearance for its Varian TrueBeam radiotherapy systems to treat medically refractory osteoarthritis in adults using low-dose radiation therapy. This marks the first expansion of Varian's radiotherapy platform beyond cancer care into chronic musculoskeletal conditions. Osteoarthritis affects over 33 million adults in the US and approximately 600 million globally. The clearance covers TrueBeam, TrueBeam STx, VitalBeam and Edge systems, offering patients with persistent pain a non-invasive outpatient treatment option that targets inflammation, reduces pain and improves joint function. The approval builds on Varian's previous regulatory clearances for non-oncological indications, including radiosurgery treatment for medically refractory essential tremor. The TrueBeam platform combines high-resolution imaging with precise dose control whilst maintaining streamlined clinical workflows.

AuntMinnieEurope.com
Dec 10th, 2025
Telix and Varian enter research collaboration

Telix and Varian enter research collaboration. Telix Pharmaceuticals and Siemens Healthineers' company Varian have agreed to develop novel clinical applications that combine Telix's theranostics products and Varian's external beam radiation therapy (EBRT) technology. The first area of focus will be in identifying opportunities to use Telix's prostate cancer PET imaging agents in selecting patients for EBRT, developing personalized treatment plans (particularly in the context of Varian's Ethos adaptive radiotherapy system), and monitoring responses to treatment, Telix said. The agreement supports both company-sponsored and investigator-led clinical studies. Varian is a key player in EBRT and working with the company will allow Telix to explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment, Telix noted. I agree to receive marketing related digital communications about products, services, events and offers that may be relevant to my given user preferences and behavior. I agree to share my information with the sponsor. I have read and agree to the privacy policy & terms of service and wish to opt-in.

AuntMinnie.com
Mar 28th, 2025
Varian, Embolx sign image-guided microcatheter agreement

Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter.